Choline to Improve Malnutrition and Enhance Cognition
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Nov 28, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether adding a special nutrient called choline to a type of therapeutic food can help improve the brain development of young children suffering from severe acute malnutrition (SAM) in Malawi. The trial will involve children aged 6 to 59 months who have signs of malnutrition, such as a very thin upper arm or swelling in their feet. Researchers want to find out if giving these children a daily dose of 500mg of choline along with their regular therapeutic food makes a difference in how well they think and learn compared to those who only receive the standard food.
To participate, children must be between 6 and 59 months old and show specific signs of malnutrition. However, those with more serious medical issues or who have recently participated in other feeding programs won't be included. Families who join the study can expect to follow certain procedures and stay in touch with the clinic for the study's duration. This trial is important because it aims to find better ways to support the health and development of children who are struggling with malnutrition, which can have lasting effects on their lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 6-59 months of age
- • mid-upper arm circumference \< 11.5 cm and/or weight-for-length z-score \< -3 and/or presence of bilateral pedal pitting edema
- • willingness to comply with all study procedures and availability for the duration of the study, including no plan to move from the catchment area of a participating clinic
- Exclusion Criteria:
- • features of complicated SAM: inability to tolerate a 30g test dose of RUTF, breathing difficulties, mental status changes, sepsis, or physician/nursing clinical assessment that the child needs immediate hospitalization
- • participation in a separate feeding program within the past month
- • known allergy to study food ingredient (peanut, milk, fish)
- • intention to move away from catchment area within 9 months
- • developmental delay
- • presence of a chronic severe medical condition (other than TB and HIV), such as congenital heart disease
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Makhwira, Chikwawa, Malawi
Mitondo, Chikwawa, Malawi
Nkhate, Chikwawa, Malawi
Chipolonga, Machinga, Malawi
Chikonde, Mulanje, Malawi
Mbiza, Mulanje, Malawi
Milonde, Mulanje, Malawi
Muloza, Mulanje, Malawi
Namasalima, Mulanje, Malawi
Naphimba, Mulanje, Malawi
Patients applied
Trial Officials
Mark J Manary, MD
Principal Investigator
Washington University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported